Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: Is cancer a disease of cellular glucose metabolism?

Medical Hypotheses

Volumn 50, Issue 1, 1998, Pages 55-59

  Boros, L G ^a   Lee, P W N ^b   Brandes, J L ^a   Cascante, M ^c   Muscarella, P ^a   Schirmer, W J ^a   Melvin, W S ^a   Ellison, E C ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LACTIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RIBOSE; THIAMINE;

CANCER; CARCINOGENESIS; DNA SYNTHESIS; GLUCOSE METABOLISM; HUMAN; PANCREAS ADENOCARCINOMA; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0031974007     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(98)90178-5     Document Type: Article

References (26)

1. Warburg O. The Metabolism of Tumors. London: Constable, 1930.
2. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-314.
3. Raylman R R, Fisher S J, Brown R S, Ethier S P, Wahl R L. Fluorine-18-fluorodeoxy-glucose-guided breast cancer surgery with a positron-sensitive probe: validation in preclinical studies. J Nucl Med 1995; 36(10): 1869-1874.
4. Torizuka T, Tamaki N, Inokuma T et al. In vivo assessment of glucose metabolism in hepato-cellular carcinoma with FDG-PET. J Nucl Med 1995; 36(10): 1811-1817.
5. Strauss L G, Conti P S. The application of PET in clinical oncology. J Nucl Med 1991; 32: 623-648.
6. Bares R, Klever P, Hauptmann S et al. F-18 fluorodeoxy-glucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. Radiology 1994; 192(1): 79-86.
7. 13C]glucose. Anal Biochem 1990; 185: 235-237.
8. 2]glucose. Biochem J 1994; 302: 31-38.
9. Lee P W N, Byerley L O, Bassilian S, Ajie H O, Clark I, Edmond J, Bergner E A. Isotopomer study of lipogenesis in human hepatoma cells in culture: contribution of carbon and hydrogen atoms from glucose. Anal Biochem 1995; 226: 100-112.
10. Portais F M, Merle M, Canioni P. Metabolic flux determination in C6 glioma cells using carbon-13 distribution upon [1-13C]glucose incubation. Eur J Biochem 1993; 217(1): 457-468.
11. Moler C, Benito M, Lorenzo M. Glucose-6-phosphate dehydrogenase gene expression in fetal hepatocyte primary cultures under nonproliferative conditions. Exp Cell Res 1994; 210: 26-32.
12. Jonas S K, Benedetto C, Flatman A et al. Increased activity of 6-phosphogluconate dehydrogenase and glucose-6-phosphate dehydrogenase in purified cell suspension and single cells from the uterine cervix in cervical intraepithelial neoplasia. Br J Cancer 1992; 66: 185-191.
13. Geertrudia N J, Use M C, Klazina S B, Dingemans K P, Kornelis J F. Experimentally induced colon cancer metastases in rat liver increase the proliferation rate and capacity for purine catabolism in liver cells. Histochemistry 1993; 100: 41-51.
14. Lehninger A L. Biochemistry, Vol. 2. New York: Worth.
15. Yamashita S, Tobinaga T, Ashizawa K et al. Glucose stimulation of protooncogene expression and deoxyribonucleic acid synthesis in rat islet cell line. Endocrinology 1988; 123(4): 1825-1829.
16. Cocco P, Dessi S, Avataneo G, Picchiri G, Heinemann E. Glucose-6-phosphate dehydrogenase deficiency and cancer in a Sardinian male population: a case control study. Carcinogenesis 1989; 10(5): 813-816.
17. Basu T K, Dickerson J W. The thiamin status of early cancer patients with particular reference to those with breast and bronchial carcinomas. Oncology 1976; 33(5-6): 250-252.
18. Zimatkina T I, Zimatkin S M, Oparin D A, Velichko M G, Ostrovskii IM. [Comparative evaluation of the action of oxythiamine and its derivatives on animals with Erhlich's ascitic cancer] [Russian]. Eksperimentalnaia Onkologiia 1986; 8(2): 68-70.
19. Trebukhina R V, Kraskovskii G V, Mel'nov S B, Motylevich ZhV, Mel'nova NI. [The effect of oxythiamine on tumor growth and certain biochemical and genetic characteristics of normal and tumor cells] [Russian]. Voprosy Meditsinskoi Khimii 1992; 38(5): 20-22.
20. Rempel A, Mathupala S P, Perdersen P L. Glucose catabolism in cancer cells: regulation of the Type II hexokinase promoter by glucose and cyclic AMP. FEBS Lett 1996; 385(3): 233-237.
21. Eigenbrodt E, Reinacher M, Schefers-Borchel U, Schefers H, Friis R. Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. Crit Rev Oncogenesis 1992; 3(1-2): 91-115.
22. Lee P W N, Boros L G, Brandes JL et al. Non-oxidative pathway of ribose synthesis in cultured pancreatic adenocarcinoma cells. American Federation for Clinical Research, February 1997, Carmel, California.
23. Melvin W S, Boros L G, Muscarella P et al. Dehydroepiandrosterone sulfate inhibits pancreatic cell proliferation in vitro and in vivo. Surgery 1997; 121(4): 392-397.
24. Fisher W E, Boros L G, O'Dorisio T M, O'Dorisio S M, Schirmer W J. Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors. J Surg Res 1996; 63: 310-313.
25. Summers M L, Wallis J G, Campbell E L, Meeks J C. Genetic evidence of a major role for glucose-6-phosphate dehydrogenase in nitrogen fixation and dark growth of the cyanobacterium Nostoc sp. strain ATCC 29133. J Bacteriol 1995; 177(21): 6184-6194.
26. Paoli G C, Morgan N S, Tabita F R, Shively J M. Expression of the cbbLcbbS and cbbM genes and distinct organization of the ebb Calvin cycle structural genes of Rhodobacter capsulatus. Arch Microbiol 1995; 164(6): 396-405.